Pulmonx LUNG
NASDAQ LUNG
$1.83 +0.01 (+0.55%)
At close: Oct 21, 2026 · 4:00 PM EDT

Pulmonx (LUNG) EBITDA Margin (2019 - 2025)

Updated

Pulmonx (LUNG) posted EBITDA Margin of -65.79% for Q3 2025, up 1.67 percentage points from -67.46% a year earlier but down 5.00 percentage points from the prior quarter.

Analysis

Pulmonx (LUNG) EBITDA Margin (2019 - 2025) Analysis & Trends

For the trailing twelve months through Sep 30, 2025, EBITDA Margin at Pulmonx was -61.16%, up 10.37 percentage points year-over-year; for FY2024, it was -67.09%, up 20.85 percentage points from FY2023.

  • Annual EBITDA Margin shows a five-year change of -13.48 percentage points (FY2019 to FY2024).
  • In prior years, Pulmonx's EBITDA Margin was -87.93% in FY2023 (+18.52 pp), -106.45% in FY2022 (-10.54 pp), -95.91% in FY2021 (+1.39 pp) and -97.30% in FY2020 (-43.69 pp).
  • Quarterly EBITDA Margin has run from a low of -141.86% in Q1 2022 to a high of -55.22% in Q4 2024 over five years.
  • On a year-over-year basis, EBITDA Margin has increased in each of the last 11 quarters, with an average year-over-year change of +16.72 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for EBITDA Margin in the past five years was Q2 2021, with a gain of 207.89 percentage points; the weakest was Q1 2021, with a drop of 64.15 percentage points.
  • According to Business Quant data, EBITDA Margin for the three prior quarters was -60.79% (Q2 2025), -63.38% (Q1 2025) and -55.22% (Q4 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Thermo Fisher Scientific 257.99 Bn 237.02 Bn 4.88 Bn 24.20%
2 Abbott Laboratories 175.01 Bn 145.44 Bn 7.27 Bn 21.86%
3 Danaher 164.93 Bn 148.74 Bn 3.61 Bn 28.51%
4 Intuitive Surgical 151.84 Bn 131.26 Bn 1.96 Bn 41.08%
5 Medtronic 119.05 Bn 84.30 Bn 6.34 Bn 25.55%
6 Stryker 113.89 Bn 100.00 Bn 4.50 Bn 29.67%
7 Boston Scientific 65.37 Bn 60.13 Bn 3.85 Bn 28.17%
8 Becton Dickinson 53.36 Bn 50.51 Bn 2.32 Bn 24.62%
9 Edwards Lifesciences 50.83 Bn 34.83 Bn 1.35 Bn 31.93%
10 Pulmonx 74.91 Mn -244.31 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -65.73%
Jun 30, 2025 -60.74%
Mar 31, 2025 -63.33%
Dec 31, 2024 -55.17%
Sep 30, 2024 -67.41%
Jun 30, 2024 -73.18%
Mar 31, 2024 -74.77%
Dec 31, 2023 -70.65%
Sep 30, 2023 -83.47%
Jun 30, 2023 -93.16%
Mar 31, 2023 -109.76%
Dec 31, 2022 -92.26%
Sep 30, 2022 -100.24%
Jun 30, 2022 -100.51%
Mar 31, 2022 -141.70%
Dec 31, 2021 -87.36%
Sep 30, 2021 -71.87%
Jun 30, 2021 -102.52%
Mar 31, 2021 -133.21%
Dec 31, 2020 -93.17%
API Access

Pulmonx EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=LUNG&period=max&api_key=YOUR_API_KEY